Cutler Group LP Forte Biosciences, Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
SELL
$0.96 - $28.0 $384 - $11,200
-400 Reduced 9.12%
3,987 $3,000
Q1 2022

Apr 14, 2022
SELL
$1.21 - $2.24 $2,541 - $4,704
-2,100 Reduced 32.37%
4,387 $6,000
Q4 2021

Jan 18, 2022
SELL
$2.02 - $3.36 $19,117 - $31,799
-9,464 Reduced 59.33%
6,487 $13,000
Q3 2021

Oct 26, 2021
BUY
$2.96 - $36.67 $47,214 - $584,923
15,951 New
15,951 $47,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email